<html><head></head><body><h1>Tobramycin Ophthalmic Solution</h1><p class="drug-subtitle"><b>Dosage Form:</b> ophthalmic solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li class="ddc-toggle-hidden">Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>Tobramycin Ophthalmic Solution Description</h2><p class="First">Tobramycin Ophthalmic Solution USP, 0.3 % is a sterile topical ophthalmic antibiotic formulation prepared specifically for topical therapy of external ophthalmic infections.<br/>
<br/>
<span class="Bold">Each mL of Tobramycin Ophthalmic Solution USP contains:</span><span class="Bold">Active</span>: tobramycin 0.3 % (3 mg). <span class="Bold">Preservative</span>: benzalkonium chloride 0.01 % (0.1 mg). <span class="Bold">Inactives</span>: boric acid, sodium sulfate decahydrate, sodium chloride, tyloxapol, sodium hydroxide and/or sulfuric acid (to adjust pH) and water for injection. Tobramycin Ophthalmic Solution USP, 0.3 % has a pH range between 7.0 and 8.0 and an osmolality of 260 to 320 mOsm/kg.</p><p>Tobramycin is a water-soluble aminoglycoside antibiotic active against a wide variety of gram-negative and gram-positive ophthalmic pathogens.</p><p>The chemical structure of tobramycin is:<br/>
<br/>
<br/>
Molecular Weight = 467.52<br/>
Molecular Formula: C<span class="Sub">18</span>H<span class="Sub">37</span>N<span class="Sub">5</span>O<span class="Sub">9</span><br/>
<br/>
Chemical name:<br/>
0-{3-amino-3-deoxy-α-D-gluco-pyranosyl-(1→4)}-0-{2,6-diamino-2,3,6-trideoxy-α-D-ribohexo -pyranosyl-(1→6)}-2-deoxystreptamine.</p><h2>Tobramycin Ophthalmic Solution - Clinical Pharmacology</h2><p class="First"><span class="Italics">In Vitro Data: In vitro studies</span> have demonstrated tobramycin is active against susceptible strains of the following microorganisms: Staphylococci, including S. a<span class="Italics">ureus</span> and S. <span class="Italics">epidermidis</span> (coagulase-positive and coagulase-negative), including penicillin-resistant strains.</p><p>Streptococci, including some of the Group A -beta-hemolytic species, some nonhemolytic species, and some <span class="Italics">Streptococcus pneumoniae</span>.</p><p><span class="Italics">Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabillis, Morganella morganii</span>, most Proteus vulgaris strains, <span class="Italics">Haemophilus influenzea and H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus</span> and some <span class="Italics">Neisseria</span> species. Bacterial susceptibility studies demonstrate that in some cases, microorganisms resistant to gentamicin retain susceptibility to tobramycin.</p><h2>INDICATIONS AND USAGE</h2><p class="First">Tobramycin Ophthalmic Solution USP, 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. Appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of Tobramycin Ophthalmic Solution USP. Clinical studies have shown tobramycin to be safe and effective for use in children.</p><h2>Contraindications</h2><p class="First">Tobramycin Ophthalmic Solution USP, 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.</p><h2>Warnings</h2><p class="First">FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION INTO THE EYE. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticaria, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If a sensitivity reaction to Tobramycin Ophthalmic Solution 0.3% occurs, discontinue use.</p><h2>Precautions</h2><h3>GENERAL</h3><p class="First">As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated.<br/>
Cross-sensitivity to other aminoglycoside antibiotics may occur; if hypersensitivity develops with this product, discontinue use and institute appropriate therapy. Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial ocular infection.</p><h3>INFORMATION FOR PATIENTS</h3><p class="First">Do not touch dropper tip to any surface, as this may contaminate the solution.</p><h3>Pregnancy</h3><p class="First">Reproduction studies in 3 types of animals at doses up to 33 times the normal human systemic dose have revealed no evidence of impaired fertility or harm to the fetus due to tobramycin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p><h3>NURSING MOTHERS</h3><p class="First">Because of the potential for adverse reactions in nursing infants from Tobramycin Ophthalmic Solution USP, a decision should be made whether to discontinue nursing the infant or discontinue the drug, taking into account the importance of the drug to the mother.</p><h3>PEDIATRIC USE</h3><p class="First">Safety and effectiveness in pediatric patients below the age of two months has not been established.</p><h3>GERIATRIC USE</h3><p class="First">No overall differences in safety or effectiveness have been observed between elderly and younger patients.</p><h2>Adverse Reactions</h2><p class="First">ADVERSE REACTIONS: The most frequent adverse reactions to Tobramycin Ophthalmic Solution USP are hypersensitivity and localized ocular toxicity, including lid itching and swelling, and conjunctival erythema. These reactions occur in less than three of 100 patients treated with Tobramycin Ophthalmic Solution USP.</p><p>   Postmarketing Experience: Additional adverse reactions identified from post-marketing use include anaphylactic reaction, Stevens-Johnson syndrome,  and erythema multiforme.</p><h2>DOSAGE &amp; ADMINISTRATION</h2><p class="First">In mild to moderate disease, instill 1 or 2 drops into the affected eye(s) every 4 hours. In severe infections, instill 2 drops into the eye(s) hourly until improvement, following which treatment should be reduced prior to discontinuation.</p><h2>How is Tobramycin Ophthalmic Solution Supplied</h2><p class="First">Tobramycin Ophthalmic Solution USP, 0.3 % is supplied in opaque white low density polyethylene bottle which is closed with natural low density polyethylene nozzle and then with tan colored high density polyethylene cap  containing tobramycin 0.3% (3 mg/mL).</p><p>5 mL in a 5 mL bottle (NDC 62332-518-05).<br/>
<br/>
<span class="Bold">Storage</span>:  Store at 2 to 25°C (36 to 77°F).<br/>
<br/>
After opening, Tobramycin Ophthalmic Solution USP, 0.3 % can be used until the expiration date on the bottle.<br/>
<br/>
<br/></p><p><span class="Bold">Manufactured for:<br/></span> Alembic Pharmaceuticals, Inc.<br/>
750 Route 202, Bridgewater, NJ 08807<br/>
USA<br/>
<br/>
Made in India</p><p><span class="Bold">Manufactured by:<br/></span> Gland Pharma Limited<br/>
D.P. Pally, Dundigal Post,<br/>
Hyderabad-500 043, India (IND)</p><p>Revised: May, 2020. </p><h2>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</h2><p class="First"><span class="Bold">Tobramycin Ophthalmic Solution USP, 0.3 % - Bottle Label:<br/>
<br/>
<br/>
Tobramycin Ophthalmic Solution USP, 0.3 % - Carton Label:<br/>
<br/>
</span></p><h2>More about tobramycin ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>6 Reviews</li>
<li>Drug class: ophthalmic anti-infectives</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tobramycin Ophthalmic &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Tobramycin (Ophthalmic) &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Conjunctivitis, Bacterial</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>